How effective is Clopidogrel for Thrombocytopenia? (a real world drug study)
Summary:
Overall ratings: 4/5 Long term ratings: 4.5/5
This is a phase IV clinical study of how effective Clopidogrel (clopidogrel) is for Thrombocytopenia and for what kind of people. The study is created by eHealthMe from 6 Clopidogrel users and is updated continuously.
What is Clopidogrel?
Clopidogrel has active ingredients of clopidogrel. It is often used in blood clots. eHealthMe is studying from 92,160 Clopidogrel users. Check the latest studies of Clopidogrel.
What is Thrombocytopenia?
Thrombocytopenia (decrease of platelets in blood) is found to be associated with 2,791 drugs and 4,873 conditions by eHealthMe. Check the latest studies of Thrombocytopenia.
6 people are studied for taking Clopidogrel in Thrombocytopenia
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Clopidogrel effectiveness for Thrombocytopenia (number of people):
Overall:
- not at all: 0
- somewhat: 0
- moderate: 3
- high: 0
- very high: 3
Long Term:
- not at all: 0
- somewhat: 0
- moderate: 1
- high: 0
- very high: 3
Gender of people who take Clopidogrel for Thrombocytopenia *:
- female: 50 %
- male: 50 %
Age of people who take Clopidogrel for Thrombocytopenia *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 100 %
Who find Clopidogrel more effective for Thrombocytopenia?
Gender of people who take Clopidogrel for Thrombocytopenia *:
- female: 33.33 %
- male: 66.67 %
Age of people who take Clopidogrel for Thrombocytopenia *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 100 %
* Approximation only. Some reports may have incomplete information.
Do you take Clopidogrel?
- You can start a phase IV clinical trial to monitor Clopidogrel safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies:
- YavasogluI, I., TurgutkayaII, A., & BolamanIII, Z., "Chlorella-induced thrombocytopenia", DATA, 2018 Jan .
- Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .
- Onder H, Arsava EM, Arat A, Topcuoglu MA, "Acute middle cerebral artery occlusion treated by thrombectomy in a patient with myelodysplastic syndrome and severe thrombocytopenia", Journal of vascular and interventional neurology, 2015 Jan .
- YavasogluI, I., TurgutkayaII, A., & BolamanIII, Z., "Chlorella-induced thrombocytopenia", DATA, 2018 Jan .
- Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .
- Onder H, Arsava EM, Arat A, Topcuoglu MA, "Acute middle cerebral artery occlusion treated by thrombectomy in a patient with myelodysplastic syndrome and severe thrombocytopenia", Journal of vascular and interventional neurology, 2015 Jan .
Related studies
Alternative drugs to, pros and cons of:
- Clopidogrel (92,160 reports)
Treatments, associated drugs and conditions:
- Thrombocytopenia (285,083 reports)
How the study uses the data?
The study is based on clopidogrel (the active ingredients of Clopidogrel) and Clopidogrel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Urticaria and Irritability - 2 seconds ago
- Could Keppra cause Angiomyolipoma? - 12 seconds ago
- Profen and Anxiolytic Therapy for Women aged 60+ - 13 seconds ago
- Profen and Anxiety And Stress for Women aged 60+ - 13 seconds ago
- Profen and Tension for Women aged 60+ - 13 seconds ago
- Profen and Stress for Women aged 60+ - 13 seconds ago
- Profen and Anxiety, Apprehension, Feeling Uptight, Jitters, Stress, Stress And Anxiety, Tension for Women aged 60+ - 14 seconds ago
- Profen and Jitters for Women aged 60+ - 14 seconds ago
- Profen and Feeling Uptight for Women aged 60+ - 14 seconds ago
- Profen and Apprehension for Women aged 60+ - 14 seconds ago